Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004872 · ClinicalTrials.gov registry record · Phase 1
Endostatin in Treating Patients With Advanced Refractory Solid Tumors
A Phase 1 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00004872: Completed Phase 1 study, sponsored by University of Wisconsin, Madison.
NCT00004872 is a Phase 1 study that has completed, run by University of Wisconsin, Madison. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004872, a Phase 1 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Endostatin may stop the growth of solid tumors by stopping blood flow to the tumor. PURPOSE: Phase I trial to study the effectiveness of endostatin in treating patients who have advanced refractory solid tumors.
Interventions
- BIOLOGICAL recombinant human endostatin
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-03 |
| Phase | Phase 1 |
What the finished NCT00004872 record still lists
NCT00004872 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which recombinant human endostatin is the first listed.
NCT00004872 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00004872 about?
NCT00004872 is a clinical study titled "Endostatin in Treating Patients With Advanced Refractory Solid Tumors". RATIONALE: Endostatin may stop the growth of solid tumors by stopping blood flow to the tumor. PURPOSE: Phase I trial to study the effectiveness of endostatin in treating patients who have advanced refractory solid tumors.
What is the current status of trial NCT00004872?
This trial is currently completed. It is a Phase 1 study. The study started on 2000-03.
What interventions are being tested in trial NCT00004872?
The interventions under investigation include: recombinant human endostatin (BIOLOGICAL).
Who is sponsoring clinical trial NCT00004872?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia